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A B S T R A C T The potent synthetic androgen methytrienolone (R 1881), which does not bind to serum proteins, was utilized to characterize binding to receptors in human androgen responsive tissues. Cytosol extracts prepared from hypertrophic prostates (BPH) were utilized as the source of receptor for the initial studies. High affinity binding was detected in the cytosol of29 of30 samples of BPH (average number of binding sites, 45.8+4.7 fmol/mg of protein; dissociation constant, 0.9+0.2 nM). This binding had the characteristics of a receptor: heat lability, precipitability by 0-33% ammonium sulfate and by protamine sulfate, and 8S sedimentation coefficient. High affinity binding was also detected in cytosol prepared from seminal vesicle, epididymis, and genital skin but not in non-genital skin or muscle. However, similar binding was demonstrated in the cytosol of human uterus. The steroid specificities of binding to the cytosol of male tissues of accessory reproduction and of uterus were similar in that progestational agents were more effective competitors than natural androgens. Binding specificities in cytosol prepared from genital skin were distinctly different and were similar to those of ventral prostate from the castrated rat in that dihydrotestosterone was much more potent than progestins in competition. Thus binding of R 1881 to the cytosol of prostate, epididymis, and seminal vesicle has some characteristics of binding to a progesterone receptor.
When the nuclear extract from BPH was analyzed, high affinity binding was demonstrated that conformed to the specificities of binding to an androgen receptor. Here dihydrotestosterone was a more potent competitor than progestational agents. Similar patterns of binding were detected in the crude nuclear extracts from seminal vesicle, epididymis, and genital skin but not in uterus, muscle, or non-genital skin. We conclude that the androgen receptor is not demon-
INTRODUCTION
The concept that steroidal hormones mediate their effects through binding to intracellular proteins, receptors, has gained wide acceptance. Based on the assumption that receptor proteins are required for hormonal action, it has been proposed that the endocrine sensitivity of a target tissue is related to the presence of cytoplasmic receptor proteins (1, 2) . If this is true, then the measurement ofthe androgen receptor content of human tissues may give further insight into the mechanisms responsible for androgen mediated growth of various tissues. At the present time, it is unclear what role the androgen receptor plays in postnatal growth and maturation of the secondary sexual characteristics, the pathogenesis of benign prostatic hyperplasia, and the hormonal dependence and resistance of carcinoma of the prostate.
In the rat ventral prostate, it has been established that the binding of dihydrotestosterone to a specific receptor is an essential step in the sequence of androgen action (2) . In man, the measurement of androgen receptors in prostatic tissue has been plagued with difficulties (3, 4) . One major obstacle has been tissue contamination with a serum protein, testosteroneestradiol binding globulin (TeBG),1 that is present in high concentration and that binds with high affinity to dihydrotestosterone. Recognizing this difficulty, a variety of methods has been devised to identify specific androgen receptors in human tissues. Several authors have attempted to purify the receptor utilizing ammonium sulphate precipitation (5, 6) or fractionation with Sephadex G-100-G-200 (6) (7) (8) (9) or to provide steroid specific suppression of dihydrotestosterone binding through the use of cyproterone acetate (10) . Although these techniques have provided some evidence for a specific receptor in human prostatic tissue, they fail to eliminate quantitatively all binding to TeBG. Other investigators have utilized sucrose density gradient centrifugation (7, 8, (11) (12) (13) (14) (15) , ionexchange chromatography (6, 14) , or protamine precipitation assays (11) as means for specific identification of androgen receptors. Although these techniques are more specific for the measurement of androgen receptors, unfortunately they have failed to demonstrate reproducibly the presence of a cytosol receptor for androgen.
Recently, Bonne and Raynaud have reported on the use of methyltrienolone (R 1881), a synthetic androgen with a relative biological activity 24 times greater than dihydrotestosterone, that binds with high affinity to the receptor but not to TeBG (16, 17) . A Preparation of nuclear extract. In experiments utilizing nuclear extract, the homogenate was initially spun at 600 g in a Sorvall RC-5 superspeed refrigerated centrifuge (Du Pont Co., Instrument Products Div., Sorvall Biomedical Div., Wilmington, Del.). The supernate was decanted and the pellet was suspended in a 1:1 volume of TED with glycerol and respun at 600 g for a further 10 min. The supemate from this spin was discarded, and the pellet was resuspended in a 1:2 volume of TED containing 0.4 M KCI. This suspension was subjected to a short burst of 5 s with the Polytron Sucrose density gradient analysis. Sucrose density gradients were prepared as described (11) by layering five different sucrose solutions (prepared with TED with glycerol) in cellulose nitrate tubes and allowing them to form a continuous gradient by diffusion; linearity was assured by measuring the refractive index of each of the fractions. Cytosol samples were ineubated-witL [-3HR 1881 (1 nM) or radioactive plus 100-fold excess nonradioactive R 1881 (0.1 ,uM) for 4 h at 0°C. Similar incubations were prepared using 5% human female serum with [3H]R 1881 or [3H]-dihydrotestosterone. To charcoal-extract the sample a 10% (vol/vol) of 5% dextran-coated charcoal (5 g acid-washed charcoal, 0.5 g dextran made up to 100 ml with Tris and EDTA buffer) was added to the sample. The mixture was allowed to stand for 15 min at 0°C. The charcoal was then pelletted by centrifugation at 4800 g for 20 min and the supernate carefully pipetted off free of charcoal. 300-,ul samples of the supematant were layered on top of the gradients, and they were centrifuged for 16 h in a SW 60 Ti rotor at 40,000 rpm (164,000 g) at 00 in a Beckman L5-65 ultracentrifuge. Bovine serum albumin was used as a marker. Fractions were collected after puncturing the bottom of the tubes by paraffin oil displacement in 200-ul aliquots. Radioactivity was monitored in a liquid scintillation counter, and bovine serum albumin was measured spectrophotometrically.
Ammonium sulfate precipitation. The 0-33% fraction was obtained by adding crystals of ammonium sulfate in the ratio of 0.196 g/ml of cytosol (19) over a period of 15 min at 4°C with constant slow stirring. The mixture was allowed to stand for 10 min and then centrifuged at 16,000 g for 20 min. The precipitate was then resuspended in a volume of TED buffer equal to the original volume of cytosol to constitute the 0-33% fraction. Ammonium sulfate crystals in the ratio of 0.107 g/ml were then added to the supemate with slow stirring. The mixture was allowed to stand for 10 min and then centrifuged at 16,000 g for 20 min. The supernate was discarded, and the precipitate was resuspended in the original volume of buffer to form the 33-50% fraction, which was then analyzed in the usual manner.
Protamine sulfate precipitation. The methods for the measurement of androgen receptor utilizing a protamine sulfate precipitation techniques were described earlier (11) . Aliquots of cytosol (200 ,ul) were combined with 400 ,ul of protamine sulfate (1.5 mg/ml) and centrifuged at 1,700 g for 10 min, producing an even white coating of precipitate on the bottom ofthe assay tube. The supernate was aspirated, 200-,ul aliquots of the steroid solution were added in concentration ranging from 70 pM to 5nM, [3H]R 1881, with or without 0.5 ,LM R 1881, and the incubations were continued for 20 h at 0°C. At the end ofthe incubation period, the steroid solutions were aspirated, and the assay tubes and pellets were washed three times with TED buffer. The precipitate adhered to the glass throughout the incubation and buffer washes. The precipitate was then extracted with two washes of absolute ethanol. The ethanol was decanted into liquid scintillation vials and was evaporated to dryness. Hydromix was added to the vials, and radioactivity was measured in a liquid scintillation counter and corrected to disintegrations per minute by means of an external gamma standard.
Thin layer chromatography. The purity ofthe [3H]R 1881 and [3Hldihydrotestosterone was determined by applying 5 pmol of each of these compounds to 20 x 20-cm sheets precoated with silica gel without gypsum. In addition, 10 ,ug of each of the nonradioactive steroids androstanedione, androstenedione, dihydrotestosterone, testosterone 3a-androstanediol, and 3,/-androstanediol was applied with each radioactive sample. The plates were developed with two ascents of the solvent system chloroform: methanol (97.5:2.5 vol/vol), air-dried and sprayed with anisaldehyde reagent, (100 ml glacial acetic acid, 2 ml concentrated H2SO4, 1 ml p-anisaldehyde), and heated at 100°C for 15 min. Within each lane, the areas corresponding to the reference steroids were marked, cut with scissors, and placed in liquid scintillation vials. The entire lane was assayed for 3H using 10 To analyze cytosol samples for steroid metabolites, aliquots were extracted with 7 ml chloroform:methanol (2:1 vol/vol). The samples were frozen at -25°C, and the liquid chloroform-methanol phase was pipetted from the aqueous phase and evaporated to dryness. The (Fig. 2B) . It was therefore concluded that the specific binding measured under these conditions was not present in serum and thus did not represent binding to testosterone-estradiol binding globulin.
To further characterize this binding as specific for a receptor the following studies were carried out: density (Fig. 3B) . The stability ofthe receptor to heat was then studied. Aliquots of cytosol heated at 45°C for 1 h were incubated with increasing concentrations of radioactive steroid at 0°C for 20 h and then subjected to Scatchard plot analysis. All specific binding was destroyed, and no Scatchard plot could be generated. A control sample of cytosol analyzed under identical conditions without prior heating contained specific binding (Kd = 1.8 nM) of a magnitude of 118 fmol/mg of protein. (Fig. 2B) . It is known that the androgen receptor is precipitated by the 0-33% fraction of ammonium sulfate, and by the polycation protamine sulfate. Utilizing a cytosol preparation containing 1710 fmol/g (of tissue) of high affinity (Kd = 1.8 nM) binding, 482 fmol/g of binding (Kd = 1.7 nM) was demonstrated in the 0-33% ammonium sulfate precipitate, and 53 fmol/g ofbinding was recovered from the 33-50% precipitate. Thus, 28% of specific binding was recovered in the 0-33% fraction, whereas only 3% was present in the 33-50% ammonium sulfate precipitate. Analysis of the supernate after precipitation with 33-50% ammonium sulfate revealed no specific binding. When aliquots of prostatic cytosol were precipitated with protamine sulfate and incubated with increasing amounts of [3H]R 1881, specific binding (Kd 1.0 nM) of small quantities (12.2 fmol/mg protein) was detected. This represented 39% of the binding detected in a control assay that was performed in the standard fashion (Fig. 4) . Ammonium sulfate and protamine sulfate precipitation caused substantial loss of recovery of receptor. However, the bulk of the receptor recovered was obtained from the 0-33% fraction with ammonium sulfate and the precipitate with protamine sulfate.
The linearity and reproducibility ofthe R 1881 assay were then tested. When cytosol prepared in the standard manner was diluted and assayed for high affinity binding, a series of Scatchard plots was obtained (Fig. 5) testosterone and similar competition studies were performed, an entirely different picture emerged (Fig.  6B) . In this case, the binding was more characteristic of TeBG, showing good displacement with testosterone, estradiol, dihydrotestosterone, and 3,-androstanediol.
R 1881 was a poor competitor, thus providing further confirmation that the binding of R 1881 to prostatic cytosol does not represent binding to contaminating serum proteins (Fig. 6B) .
To further characterize the steroid specificity of binding of [3H]R 1881 to prostatic cytosol, competition experiments were done utilizing progestational agents. When progesterone was used as the competing steroid, it was found that progesterone competed somewhat better than dihydrotestosterone for binding sites. The synthetic progestin R 5020 was an even more potent competitor (Table II) . Because it has been suggested that R 1881 may bind to the progesterone receptor, the possibility that the protein being measured was a progesterone receptor was considered. Scatchard (Fig. 7) .
We next proceeded to compare the steroid specificity of [3H]R 1881 binding to cytosol prepared from sex accessory tissues (prostate, seminal vesicle, and epididymis), to genital skin (scrotal skin and infant foreskin), to uterus, and to rat ventral prostate (Table II) . In these studies the steroid specificity patterns of BPH, seminal vesicle, and epididymis were indistinguishable and exhibited striking similarity to that of uterine cytosol. In all these tissues, progestational agents were much more potent than dihydrotestosterone in competing for binding sites. In uterine cytosol, dihydrotestosterone was totally ineffective as a competitor. Binding to genital skin and rat ventral prostate was distinctly different. Here dihydrotestosterone was a highly potent competitor, whereas progestational agents were ineffective (Table II) . These studies indicate that the steroid specificity of binding of [3H]R 1881 to the cytosol of the BPH, seminal vesicle, and epididymis does not approximate the specificity of binding to the androgen receptor as classically described in ventral prostate from the castrated rat. Although the binding is heat labile, precipitable by 0-33% ammonium sulfate and protamine sulfate, exhibits high affinity and tissue specificity, and sediments in the 8S region on density gradient centrifugation, it has steroid specificities more (Table III) . The relative binding affinity of dihydrotestosterone was 83, whereas that of R 5020 was 6. Similar patterns of steroid specificity were seen with the nuclear extracts of seminal vesicle, epididymis, and scrotal skin. No high affinity binding was seen, however, in the nuclear extracts of muscle and non-genital skin. When nuclear extract from uterus was analyzed under similar conditions, although specific binding was detected, the steroid specificity was markedly different with dihydrotestosterone being an extremely poor competitor, whereas R 5020 was potent with a binding affinity of 75 (Table III) . The steroid specificity of binding of [3H]R 1881 to the nuclear extract of male sex accessory tissues is thus distinctly different from the binding to cytosol and bears the characteristics of binding to the androgen receptor.
It was apparent that binding studies with crude nuclear preparations may not in fact represent binding to the nuclear fraction, but may represent binding to a compartmentalized cytoplasmic fraction. Crude and purified nuclei, and their associated cytoplasmic fractions were prepared from the same patient and analyzed using Scatchard plots and steroid specificity reactions. Comparable results were obtained with both methods allowing for a loss of receptor on purification (Table IV) . Analysis of the stromal debris did not demonstrate any high affinity binding to [3H]R 1881.
DISCUSSION
The androgen receptor has been studied most extensively in the rat ventral prostate. On sucrose density gradient centrifugation, the receptor sediments as a polydispersed aggregate in low salt solutions not containing glycerol; in the presence of glycerol, it sediments as an 8S. It is completely destroyed by heating to 50°C for 1 h (20, 21) . The receptor is precipitated (3, 4) . In this study we have identified another factor, the presence of a cytoplasmic protein that binds progestational agents, that interferes with the demonstration of a soluble cytosol receptor for androgen.
Recently, Bonne and These data demonstrate the presence of a soluble receptor that binds progestins with great avidity in the cytosol of human BPH, seminal vesicle, and epididymis. It is unclear what function this receptor fulfills and why it is present. It is well known that circulating levels of progesterone are quite low (30 ng/100 ml) in men (23) , and that progesterone is not considered a major tropic hormone for the male sex accessory tissues. However, it is accepted that progestational agents can modify androgen action by potentiation or inhibition. The mechanism by which these synandrogenic and antiandrogenic responses are mediated is not understood well, but this phenomenon may be related to the presence of receptor proteins for progestational agents in the cytosol of some androgen responsive tissues (24, 25) . Finally, because the regulation ofthe progesterone receptor is under the control of estrogen (26) , the presence of the cytosol receptor characterized here in some, but not all sex accessory tissues, may indicate that estrogen has a primary role in modulating the growth and function of these target organs. It is of interest that all tissues in which the cytoplasmic receptor was demonstrable were removed from aging males where one would predict that any estrogenic effect would be magnified, and it is conceivable that this receptor may not be present in tissues taken from young individuals. If this is true, this finding may provide important insight into the pathogenesis of BPH.
When the nuclear extract of benign prostatic hyperplasia was analyzed, high affinity binding was demonstrated likewise. This binding was both tissue-and steroid-specific. Dihydrotestosterone was a potent competitor, whereas progestational agents were not. Similar patterns of binding were also seen in the crude nuclear extracts prepared from seminal vesicle, epididymis, and genital skin. Although high affinity binding was detected in extracts of uterine nuclei, this was competed for by progestational agents, but not by dihydrotestosterone. It Based on the known mechanism of steroid hormone action, in the presence of normal levels of endogenous steroid, most of the receptor molecules should be shifted to the nucleus. In the ventral prostate of the rat, it is difficult to demonstrate the presence of cytoplasmic receptor in the non-castrate animal (27) . In man, it is well known that in the prostate (28) and possibly in other sex accessory tissues, the endogenous level of androgen is high. Consequently, it is not surprising that a large proportion of the demonstrable androgen receptor is present in the nucleus. Although these findings do not disprove the presence of a cytosol receptor for androgen in the prostate, they do suggest that it is exceedingly difficult to demonstrate. We therefore suggest that in man, studies of the androgen receptor should be directed at the nucleus. Because steroid hormones exert their major influence within the nucleus of target tissues, such studies may provide valuable insight into the role of androgen receptors in the regulation of the normal and abnormal growth and development of male sex accessory tissues.
